Array ( [0] => Applebot/0.1 [1] => facebookexternalhit/1.1 [2] => LinkedInBot/1.0 [3] => meta-externalagent/1.1 [4] => Amazonbot/0.1 [5] => BLEXBot/1.0 [6] => DotBot/1.2 [7] => Qwantbot/1.0_1997801 [8] => AhrefsBot/7.0 [9] => DataForSeoBot/1.0 [10] => MatchorySearch/1.3 [11] => WRTNBot/1.0 [12] => Sogou web spider/4.0 [13] => MojeekBot/0.11 [14] => Yeti/1.1 [15] => SeznamBot/4.0 [16] => SemrushBot-SI/0.97 [17] => MistralAI-User/1.0 [18] => Qwantbot/1.0 [19] => coccocbot-web/1.0 [20] => coccocbot-image/1.0 [21] => PlagAwareBot/3.2 [22] => Barkrowler/0.9 [23] => AwarioSmartBot/1.0 [24] => PetalBot [25] => archive.org_bot [26] => Iframely/1.3.1 [27] => LogRocket-AssetCacher [28] => Slackbot 1.0 [29] => node-fetch/1.0 [30] => MJ12bot/v1.4.8 [31] => MJ12bot/v2.0.0 [32] => Timpibot/0.9 [33] => AwarioBot/1.0 [34] => MJ12bot/v2.0.1 [35] => Qwantbot/1.0_2850318 [36] => SiteAuditBot/0.97 [37] => Scrapy/2.11.2 [38] => CCBot/2.0 [39] => MJ12bot/v2.0.2 [40] => Scrapy/2.13.3 [41] => WordPress/6.8.3 [42] => MJ12bot/v2.0.4 [43] => SemrushBot/7~bl [44] => Qwairy-Bot/1.0 [45] => Embedly/0.2 [46] => GeedoProductSearch [47] => SemrushBot [48] => vkShare [49] => inkrich [50] => Discordbot/2.0 [51] => IbouBot/1.0 [52] => trafilatura/1.6.3 [53] => AnsehnBot/1.0 [54] => WP-URLDetails/6.8.3 [55] => HubSpot Crawler [56] => ShapBot/0.1.0 [57] => udu/1.6.5 [58] => aiohttp/3.13.1 [59] => l9scan/2.0 [60] => Trident/5.0 [61] => SmartBotCrawler/1.0 [62] => ) The user agent is not in the allowed list.Array ( [0] => pingbot/2.0 [1] => Googlebot/2.1 [2] => ChatGPT-User/1.0 [3] => PerplexityBot/1.0 [4] => OAI-SearchBot/1.0 [5] => GPTBot/1.2 [6] => Perplexity-User/1.0 [7] => YandexBot/3.0 [8] => YandexFavicons/1.0 [9] => AdsBot-Google-Mobile [10] => AdsBot-Google [11] => Gemini-Deep-Research [12] => DuckAssistBot/1.1 [13] => DuckDuckBot/1.1 [14] => GoogleOther [15] => YandexRenderResourcesBot/1.0 [16] => YandexImages/3.0 [17] => DuckAssistBot/1.2 [18] => Baiduspider/2.0 [19] => Baiduspider-render/2.0 [20] => bingbot/2.0 [21] => YandexUserproxy [22] => Pingdom.com_bot_version_1.4_ [23] => GPTBot/1.3 [24] => PingdomPageSpeed/1.0 [25] => YandexMobileBot/3.0 [26] => OAI-SearchBot/1.3 [27] => ClaudeBot/1.0 [28] => OAI-SearchBot/1.3 [29] => ) The user agent is an allowed/known agent.
Johne's Disease Diagnostics Market Size & Growth Forecast 2026–2035, By Segments (End-use, Animal Type, Test Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Base Year Value (2025)
USD 705 Million
CAGR (2026-2035)
5.6%
Forecast Year Value (2035)
USD 1.22 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035
Johne's Disease Diagnostics Market Intelligence Snapshot:
-
Regional Market Dynamics:
- North America captured a 33.92% share in 2025, supported by established veterinary diagnostic infrastructure, routine livestock disease surveillance, and strong collaboration among veterinarians, laboratories, and producers.
- Asia Pacific is projected to grow at a 6.33% CAGR as stronger animal health monitoring, expanding livestock industries, and improved access to veterinary diagnostics increase testing adoption.
-
Segment Momentum:
- Veterinary Hospitals & Clinics accounted for 55.65% of the market in 2025 because they are the primary settings for disease screening, diagnosis, and herd health management.
- Sheep is the fastest-growing animal type as disease surveillance and early diagnostic adoption expand across flock health management programs.
-
Market Expansion Drivers:
- Rising livestock population increasing demand for routine disease diagnostics.
- Government-led Johne’s disease eradication programs strengthening herd testing adoption.
- Expansion of automated point-of-care veterinary diagnostic testing solutions.
-
Leading Market Participants:
Top players in the johne's disease diagnostics market include IDEXX Laboratories, Inc. (United States), Thermo Fisher Scientific Inc. (United States), Zoetis Inc. (United States), bioMérieux S.A. (France), INDICAL BIOSCIENCE GmbH (Germany), IDvet SAS (France), PBD Biotech Ltd. (United Kingdom), Tetracore, Inc. (United States), VMRD, Inc. (United States), MV Diagnostics Ltd. (United Kingdom).
Global Market Forecast Snapshot:
-
Market Outlook:
- 2025 Market Size: USD 705 Million
- 2026 Market Size: USD 15.2 billion
- Projected Market Size: USD 1.22 Billion by 2035
- Growth Forecasts: 5.6% CAGR (2026-2035)
-
Regional and Segment Outlook:
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Veterinary Hospitals & Clinics (End-use) | Cattle (Animal Type) | PCR (Test Type)
- Emerging Opportunity Segment: Veterinary Hospitals & Clinics (End-use) | Sheep (Animal Type) | ELISA (Test Type)
Market Growth Drivers and Industry Trends
Rising livestock population increasing demand for routine disease diagnosticsAs herd sizes expand, producers face greater exposure to productivity losses linked to chronic infectious diseases that can spread silently before clear clinical signs appear. This is increasing reliance on regular screening protocols, especially in dairy and breeding operations where animal health directly affects milk yield, reproductive performance, and culling decisions. In the johne's disease diagnostics market, a larger livestock base translates into more animals entering surveillance cycles, more herd-level risk assessments, and stronger purchasing of ELISA, PCR, and fecal testing services as farms and veterinarians move from reactive case confirmation toward routine herd management.
Government-led Johne’s disease eradication programs strengthening herd testing adoption
Official control and eradication initiatives are shaping testing behavior by turning Johne’s disease surveillance into a structured compliance activity rather than an optional health measure. When governments and animal health authorities introduce herd status programs, reporting frameworks, movement controls, or subsidized testing pathways, producers are more likely to adopt periodic screening to maintain market access and reduce the risk of restrictions on breeding stock sales. This is strengthening demand in the johne's disease diagnostics market by creating recurring test volumes through organized herd certification, follow-up testing, and veterinarian-led monitoring tied to formal disease management plans.
Expansion of automated point-of-care veterinary diagnostic testing solutions
The spread of automated point-of-care systems is changing how testing is deployed by reducing turnaround times and simplifying diagnostic workflows in veterinary settings. Clinics, farm veterinarians, and field service providers can process samples with less dependence on centralized laboratories, which makes screening more practical during routine herd visits and supports faster isolation or management decisions for suspected animals. In the johne's disease diagnostics market, this shift is increasing market penetration by broadening access to testing in dispersed livestock operations and by encouraging more frequent use where convenience, speed, and workflow efficiency strongly influence adoption.
| Growth Driver Assessment Framework | |||||
| Growth Driver | Impact On CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising livestock population increasing demand for routine disease diagnostics | 1.90% | Moderate | Asia Pacific, North America | Medium | Near Term |
| Government-led Johne’s disease eradication programs strengthening herd testing adoption | 2.10% | High | Europe, North America | Medium | Mid Term |
| Expansion of automated point-of-care veterinary diagnostic testing solutions | 1.60% | Moderate | Asia Pacific, Europe | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions - Click to get your customized report now!
Regional Demand Dynamics
Largest Region
North America
33.92% Market Share in 2025
North America held a 33.92% share of the johne's disease diagnostics market in 2025, supported by its established veterinary diagnostic infrastructure, routine disease surveillance in commercial livestock systems, and wider use of laboratory-based testing across cattle operations. The region’s leadership is reinforced by the practical need for early detection and herd-level disease management, particularly where producers and animal health stakeholders rely on regular screening to limit productivity losses and support control programs. Strong integration between veterinarians, diagnostic laboratories, and livestock producers also helps sustain testing volumes by making sample collection, confirmation, and follow-up actions more consistent in day-to-day farm management.
Asia Pacific is projected to expand at a 6.33% CAGR over the forecast period, with growth in the johne's disease diagnostics market being driven by the gradual strengthening of animal health monitoring across expanding livestock industries. Rising attention to herd productivity and disease-related economic losses is increasing the use of diagnostic testing in practice, especially as producers and veterinary systems place greater emphasis on earlier identification of infections. The region’s acceleration is also supported by improving access to veterinary services and diagnostic capabilities, which is making testing more feasible across a broader base of livestock operations.
| Regional Market Attractiveness & Strategic Fit Matrix | |||||
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub | Advanced | Developing | Advanced | Emerging | Nascent |
| Cost-Sensitive Region | Low | Medium | Low | High | High |
| Regulatory Environment | Supportive | Neutral | Restrictive | Neutral | Neutral |
| Demand Drivers | Moderate | Weak | Moderate | Weak | Weak |
| Development Stage | Developed | Developing | Developed | Emerging | Emerging |
| Adoption Rate | Medium | Low | Medium | Low | Low |
| New Entrants / Startups | Sparse | Sparse | Sparse | Sparse | Sparse |
| Macro Indicators | Strong | Stable | Stable | Weak | Weak |
Key Country Insights
The U.S. Johne's disease diagnostics market focuses on routine herd surveillance and early disease detection across commercial livestock operations. Diagnostic providers in the U.S. continue enhancing laboratory testing capacity and integrated herd management solutions for producers.
Japan prioritizes reliable Johne's disease diagnostics as part of broader livestock biosecurity initiatives. Veterinary services in Japan increasingly utilize laboratory-based screening and preventive herd health programs to minimize disease transmission risks.
South Korea continues strengthening Johne's disease diagnostics through coordinated veterinary surveillance and livestock health management efforts. Diagnostic laboratories in South Korea focus on efficient testing capabilities that support timely disease identification across cattle farms.
Germany emphasizes accurate diagnostic testing that supports animal health management and livestock productivity. German veterinary laboratories increasingly adopt standardized diagnostic workflows to improve disease monitoring and farm-level decision-making.
France integrates Johne's disease diagnostics into dairy herd management programs aimed at improving animal health outcomes. French veterinary stakeholders emphasize consistent screening practices and laboratory collaboration to support informed livestock management decisions.
Italy supports the Johne's disease diagnostics market through preventive testing and veterinary monitoring across livestock operations. Italian producers increasingly incorporate routine diagnostic assessments into herd health strategies to reduce operational risks and improve disease control practices.
Segment Leadership and Growth Trends
Veterinary Hospitals & Clinics accounted for a 55.65% share of the johne's disease diagnostics market in 2025, reflecting their central role in routine animal health assessment, disease screening, and case-based diagnostic decision-making. This end-use segment continues to expand because these settings are where suspected infections are most directly identified, tested, and managed, especially when herd owners require timely diagnostic support tied to treatment planning, animal segregation, or broader disease control measures. Their combined advantage of established testing workflows, direct access to affected animals, and consistent demand from livestock care makes Veterinary Hospitals & Clinics both the current leader and the strongest source of ongoing growth in the johne's disease diagnostics market.
Animal Type Segment Analysis: Cattle (Largest Segment) vs Sheep (Fastest-Growing Segment)
Cattle held an 82.65% share of the johne's disease diagnostics market in 2025, making this the dominant animal type segment due to the disease’s direct relevance to commercial cattle health management and herd productivity. The segment’s leadership is underpinned by the practical need for regular monitoring in cattle populations, where diagnostic use is closely tied to infection control, production continuity, and herd-level management decisions. This concentration of testing demand keeps cattle at the center of the johne's disease diagnostics market.
Sheep represent the fastest-growing segment in the johne's disease diagnostics market as diagnostic attention expands beyond core cattle applications into other susceptible livestock populations. Growth in this segment is being backed by rising recognition of the need for earlier detection and more structured disease surveillance in sheep, particularly where flock health management depends on identifying infection before broader transmission affects animal performance. Compared with more established animal type segments, sheep are gaining momentum because diagnostic adoption is still building from a lower base and becoming more integrated into routine livestock health practices.
| Report Segmentation | |||
| Segment | Sub-Segment | Largest Segment | Fastest Growing Segment |
|---|---|---|---|
| End-use | Veterinary Hospitals & Clinics, Others | Veterinary Hospitals & Clinics | Veterinary Hospitals & Clinics |
| Animal Type | Cattle, Goat, Sheep | Cattle | Sheep |
| Test Type | ELISA, PCR, AGID | PCR | ELISA |
Read our Research ApproachCompetitive Landscape and Market Positioning
Company Profile
Business Overview Financial Highlights Product Landscape SWOT Analysis Recent Developments Company Heat Map Analysis
1. IDEXX Laboratories Inc. (United States)
2. Thermo Fisher Scientific Inc. (United States)
3. Zoetis Inc. (United States)
4. bioMérieux S.A. (France)
5. INDICAL BIOSCIENCE GmbH (Germany)
6. IDvet SAS (France)
7. PBD Biotech Ltd. (United Kingdom)
8. Tetracore Inc. (United States)
9. VMRD Inc. (United States)
10. MV Diagnostics Ltd. (United Kingdom)
Rising focus on livestock disease management is strengthening the johne's disease diagnostics market, with ongoing research supporting the development of rapid, accurate diagnostic technologies that improve disease detection and herd health management.
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| IDEXX Laboratories | 2024 | IDEXX expanded PCR-based Johne’s disease testing platforms to support large-scale dairy herd screening. The initiative enhances diagnostic scalability and enables more efficient disease surveillance in livestock populations, reinforcing IDEXX’s position in veterinary molecular diagnostics and supporting broader adoption of PCR-based screening in animal health management systems. |
| Zoetis | 2025 | Zoetis introduced integrated livestock health management solutions incorporating advanced diagnostic analytics across animal health workflows. The development strengthens its position in end-to-end herd health monitoring, combining diagnostics and data-driven insights to improve disease detection and management across livestock production systems. |
| Thermo Fisher Scientific, Inc. | 2023 | Thermo Fisher Scientific increased investment in automated veterinary molecular diagnostic systems, supporting expansion of high-throughput testing capabilities. The initiative enhances laboratory efficiency and scalability for livestock disease diagnostics, reinforcing the company’s role in enabling advanced molecular workflows in veterinary healthcare infrastructure. |
| INDICAL BIOSCIENCE GmbH | 2024 | INDICAL BIOSCIENCE launched enhanced multiplex PCR assays for livestock disease detection, improving simultaneous identification of multiple pathogens. The development strengthens diagnostic precision and efficiency in veterinary laboratories, supporting broader adoption of multiplex molecular testing in livestock disease control and surveillance programs. |
| PBD Biotech | 2025 | PBD Biotech expanded its veterinary diagnostic research programs focused on rapid detection of mycobacterial diseases, including Johne’s disease. The initiative supports advancement of faster diagnostic methodologies and reinforces innovation in early detection tools for livestock disease management and control strategies. |
Frequently Asked Questions
What is the current size of the johne's disease diagnostics market?
The market size of the johne's disease diagnostics is estimated at USD 739.27 million in 2026.
What is the forecasted size of the johne's disease diagnostics industry?
Johne's Disease Diagnostics Market size is forecast to climb from USD 705 million in 2025 to USD 1.22 billion by 2035 expanding at a CAGR of over 5.6% during 2026-2035.
Why is routine herd screening becoming a strategic priority in the Johne's disease diagnostics market?
Expanding livestock populations and greater emphasis on herd productivity are increasing adoption of routine diagnostic testing, allowing producers and veterinarians to identify infections earlier and strengthen herd-level disease management practices.
How are operational changes improving diagnostic adoption in the Johne's disease diagnostics market?
Automated point-of-care diagnostic systems simplify testing workflows, reduce turnaround times, and make routine screening more practical during veterinary visits, supporting broader testing adoption across dispersed livestock operations.
Why do veterinary hospitals and clinics lead the Johne's disease diagnostics market?
Veterinary Hospitals & Clinics accounted for 55.65% of the market in 2025 because they are the primary settings for disease screening, diagnosis, and herd health management.
Which animal type is growing the fastest in the Johne's disease diagnostics market?
Sheep is the fastest-growing animal type as disease surveillance and early diagnostic adoption expand across flock health management programs.
Why does North America lead the Johne's disease diagnostics market?
North America captured a 33.92% share in 2025, supported by established veterinary diagnostic infrastructure, routine livestock disease surveillance, and strong collaboration among veterinarians, laboratories, and producers.
What is driving growth in the Johne's disease diagnostics market in Asia Pacific?
Asia Pacific is projected to grow at a 6.33% CAGR as stronger animal health monitoring, expanding livestock industries, and improved access to veterinary diagnostics increase testing adoption.
Who are the leading players in the johne's disease diagnostics landscape?
Top players in the johne's disease diagnostics market include IDEXX Laboratories, Inc. (United States), Thermo Fisher Scientific Inc. (United States), Zoetis Inc. (United States), bioMérieux S.A. (France), INDICAL BIOSCIENCE GmbH (Germany), IDvet SAS (France), PBD Biotech Ltd. (United Kingdom), Tetracore, Inc. (United States), VMRD, Inc. (United States), MV Diagnostics Ltd. (United Kingdom).
Our Clients
Why Choose Us
Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.
Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.
Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.
Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.
Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.
Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.
Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.
Select Licence Type
